In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)
There are 700,000 new cases of lung cancer each year and NSCLC constitutes about 80% of the total lung cancer patient population. Pharma have been attracted by the high incidence of this disease and the NSCLC pipeline has grown substantially.
Recent approvals reinvigorate mCRPC market
Edit my basket
© Datamonitor 2012. All rights reserved
Terms & Conditions